1. Development of interferon beta-neutralising antibodies in multiple sclerosis—a systematic review and meta-analysis

   • Karthik Govindappa
   • Jean Sathish
   • Munir Pirmohamed

   Review 14 August 2015 Pages: 1287 - 1298

   

2. Different methods, different results—how do available methods link a patient’s anticholinergic load with adverse outcomes?

   • Tanja Mayer
   • Walter E Haefeli
   • Hanna M Seidling

   Review 08 September 2015 Pages: 1299 - 1314

   

3. Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study

   • Jean-Philippe Collet
   • Jean-Sébastien Hulot
   • for the ARCTIC investigators

   Pharmacodynamics 13 August 2015 Pages: 1315 - 1324

   

4. Efficacy and tolerability of canagliflozin as add-on to metformin in the treatment of type 2 diabetes mellitus: a meta-analysis

   • Ting Yang
   • Min Lu
   • Yimin Cui

   Pharmacodynamics 19 August 2015 Pages: 1325 - 1332

   

5. Simulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs

   • Jongtae Lee
   • Sangil Jeon
   • Dong-Seok Yim

   Pharmacodynamics 09 September 2015 Pages: 1333 - 1339

   

6. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children

   • Limin Liu
   • Limei Zhao
   • Yanan Ma

   Pharmacogenetics 26 August 2015 Pages: 1341 - 1347

   

7. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia

   • Sunitha Kodidela
   • Suresh Chandra Pradhan
   • Debdatta Basu

   Pharmacogenetics 03 September 2015 Pages: 1349 - 1358

   

8. Iontophoresis driven concentrations of topically administered diclofenac in skeletal muscle and blood of healthy subjects

   • Richard Crevenna
   • Angela Burian
   • Markus Zeitlinger

   Pharmacokinetics and Disposition 14 August 2015 Pages: 1359 - 1364

   

9. Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of inclacumab in healthy Japanese and Caucasian subjects

   • Mary Morrison
   • Guiseppe Palermo
   • Christophe Schmitt

   Pharmacokinetics and Disposition 12 September 2015 Pages: 1365 - 1374

   

10. Medication errors detected in non-traditional databases: types of errors in methotrexate dosing as listed in four different Danish registers

    • Helene Perregaard
    • Jeffrey K. Aronson
    • Annemarie Hellebek

    Pharmacoepidemiology and Prescription 11 August 2015 Pages: 1375 - 1379

    

11. A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinic

    • Ramon S. Dekker
    • Tim Schutte
    • Milan C. Richir

    Pharmacoepidemiology and Prescription Open access 14 August 2015 Pages: 1381 - 1387

    

12. Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults

    • E Barrenberg
    • E Garbe

    Pharmacoepidemiology and Prescription 25 August 2015 Pages: 1389 - 1396

    

13. Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review

    • Gertrud Gansmo Kongsholm
    • Anna Katrine Toft Nielsen
    • Per Damkier

    Pharmacoepidemiology and Prescription 15 September 2015 Pages: 1397 - 1402

    

14. Adverse events during placebo vs. no drug administration—results of a randomised interventional trial in 160 volunteers

    • Frank Erbguth
    • Angelika Hamacher-Erbguth
    • Fritz Sörgel

    Letter to the Editor 14 August 2015 Pages: 1403 - 1405

15. Tendinopathy after ofloxacin ear drops

    • Aurélie Grandvuillemin
    • Elise Contant
    • Anne Dautriche

    Letter to the Editors 14 August 2015 Pages: 1407 - 1408

16. Effect of hepatitis B and C clearance on atazanavir exposure

    • Cristina Gervasoni
    • Dario Cattaneo
    • Laura Milazzo

    Letter to the Editors 23 August 2015 Pages: 1409 - 1411

    

17. Rivaroxaban-induced hair loss

    • Basile Chrétien
    • Anne Besnard
    • Sophie Fedrizzi

    Letter to the Editors 25 August 2015 Pages: 1413 - 1414